Drawing for TAKE2

USPTO serial 97261874

TAKE2

Reviewed by CopyMark Law Group

Reg. 7283042Status 700Registered
Filing date
Status date
Registration date
Jan 23, 2024
Examiner
NADELMAN, ANDREA KOYNER
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TAKE2?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tama L. Drenski

Tama L. Drenski RENNER KENNER GREIVE BOBAK TAYLOR & WEBER CO. LPA106 S. MAIN STREETSUITE 400AKRON, OH 44308-1412

Goods and services

ClassDescriptionStatusFirst use
001(Based on 44(e)) Chemicals used in industry and science; assays and reagents for scientific and research use, namely, assays and reagents for use in genetic research, assays for research purposes, reagents for scientific and research use; diagnostic reagents for scientific use; diagnostic preparations for scientific use; diagnostic test kits for use in the fields of scientific, pharmaceutical and medical research, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; diagnostic test kits for scientific use, namely, kits comprised of diagnostic reagents and preparations for scientific use; chemical reagents for non-medical purposes; chemical test kits for analysis and detection of genetic information and diseases for scientific, clinical or medical laboratory use; chemical reagents and kits containing same, each for scientific purposes; reagents, enzymes, and nucleotides for medical research use; Chemical preparations for pharmaceutical or medical purposes, namely, for chemical additives for use in the manufacture of pharmaceuticals for cancerACTIVE—
005(Based on 44(e)) Pharmaceutical, medical and veterinary preparations, namely, chemical preparations for pharmaceutical or medical purposes, namely, for treating cancer, medical preparations for the treatment of cancer, pharmaceutical products for the treatment of cancer; medical diagnostic reagents; clinical diagnostic reagents, namely, reagents for use in medical genetic testing; reagents, enzymes, and nucleotides for use in genetic testing for medical and diagnostic purposes, namely, reagents for medical use, diagnostic reagents for medical use, enzymes for medical purposes, reagents for medical use and medical diagnostic reagents, and screening kits comprised of reagents for medical diagnostics and for medical screening use; reagent kits composed of medical diagnostic reagents and medical diagnostic reagent beads with attached biomolecules for clinical diagnostic purposes; diagnostic tests and test kits for determination of genetic information for medical purposes, namely, genetic identity tests comprised of reagents for medical purposes; pharmaceutical products for ophthalmological use, for the treatment of cancer, for treating diabetes, for the treatment of bone disease; diagnostic medical reagents for medical use; medical diagnostic test kits, namely, medical diagnostic preparations and screening kits comprised of reagents for medical diagnostics and medical screening use, diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, namely, cancerACTIVE—
009(Based on 44(e)) Automated laboratory apparatus for use in analysis of biomolecules for scientific purposes; nucleic acid sequencers for scientific purposes; non-medical imaging devices for gemstones, roots, for clinical diagnostic purposes and scientific research; laboratory equipment, namely, cupels, funnels, microarrays, and electric bath heaters; scientific equipment and instruments, namely, ultra-high vacuum champers and scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor; DNA testing apparatus which carry or hold DNA samples for non-medical purposes; Ophthalmic instruments, namely, ophthalmic lensesACTIVE—
010(Based on 44(e)) Surgical apparatus and instruments for medical use, namely, incubators for medical purposes, apparatus for use in medical analysis, namely, medical diagnostic instruments for the analysis of body fluids; and ophthalmic instruments, namely, lasers for ophthalmic purposes; medical diagnostic apparatus, namely, ultrasonic medical diagnostic apparatus and hematology analyzers for medical diagnostic uses; analytical apparatus for medical purposes, namely, medical instruments for analyzing bacteria and breath gas analyzers for medical diagnostics; medical apparatus for detecting cancer; cholesterol meters; endoscopic equipment for medical purposes; enema apparatus for medical purposes; physical exercise apparatus, for medical purposes; gloves for medical purposes; magnetic resonance imaging apparatus for medical purposes; massage apparatus for medical purposes; medical apparatus and instruments for detecting and treating cancer; DNA testing apparatus which carry or hold DNA samples for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 23, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jan 23, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 14, 2023DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Dec 14, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 14, 2023IUCNNOTICE OF ALLOWANCE CANCELLED—
Nov 14, 2023D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Nov 14, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 19, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 19, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 30, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 16, 2023OTHECASE RETURNED TO EXAMINATION—
Aug 16, 2023IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 11, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 16, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 16, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 26, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 10, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 13, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 21, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 21, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 26, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 25, 2022ALIEASSIGNED TO LIE—
Sep 14, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 22, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 22, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2022DOCKASSIGNED TO EXAMINER—
Feb 15, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 14, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance